About: Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1987

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1987 (uk) im Mai 1987 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1987 (ast) scientific article published on 01 May 1987 (en)
publication date	wds:Q68843632-625CECB1-4F98-4F30-A87B-5DE52862ED0F
publication date	1987-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q68843632-008C627F-352A-4AC2-9255-692B7B5F2CC3 wds:Q68843632-18B5BABA-38EE-4748-B68F-E7C8EFF3AAB0 wds:Q68843632-4F233642-2DDA-46E2-AF98-07C46BD85356 wds:Q68843632-5E8307C5-0B15-432D-AE69-06D39163F92D wds:Q68843632-9E574A55-A7A5-44BA-8DC5-03E95A393801 wds:Q68843632-A4863982-EE5B-45E4-8BD2-E139DA49138C
author name string	A Richens S Jawad A W Peck M J Hamilton W C Yuen J R Oxley
rdfs:label	Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy (en) Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy (nl)
skos:prefLabel	Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy (en) Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy (nl)
name	Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy (en) Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy (nl)
title	wds:Q68843632-D0DD7169-11AB-42F0-A939-D38F80EA6C08
title	Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy (en)
page(s)	wds:Q68843632-6B3C518C-4A2C-4EFC-ABC3-BF730736C110
page(s)	194-201
instance of	wds:Q68843632-2C4EB7A4-487D-4566-8416-58C27BE884E6
instance of	scholarly article
main subject	wds:Q68843632-09A68A63-DF53-4635-8CEE-725F076FBC55 wds:Q68843632-157812B5-72D6-4B32-821E-14E7821C9170
main subject	pharmacokinetics lamotrigine
PubMed ID	wds:Q68843632-AE008166-9A0C-4E68-BC04-479F5E533277
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3504397
PubMed ID	3504397
published in	wds:Q68843632-6A323423-A328-4D3E-A8D6-8AA5E1E0C932
published in	Epilepsy Research
issue	wds:Q68843632-7FA8A153-4A63-4FE6-BBA7-C5271F785163
volume	wds:Q68843632-A576D5CD-2FEA-4EDC-8BE5-8C4175CF2EE8
issue	3
volume	1
DOI	wds:Q68843632-292E035D-5CB8-4113-9E90-6E69CCF4CDAA
DOI	http://dx.doi.org/10.1016/0920-1211(87)90041-6
DOI	10.1016/0920-1211(87)90041-6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68843632
is cites work of	Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures Pharmacokinetics of haloperidol: an update Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation Bidirectional interaction of valproate and lamotrigine in healthy subjects. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations Lamotrigine: a review of its use in bipolar disorder Lamotrigine clinical pharmacokinetics Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy Pharmacokinetic optimisation of anticonvulsant therapy Antiepileptic drugs. A review of clinically significant drug interactions. Comparative pharmacokinetics of the newer antiepileptic drugs Pharmacokinetic interactions of the new antiepileptic drugs Overview of the Clinical Efficacy of Lamotrigine Interactions between valproate, glutamate, aspartate, and GABA with respect to uptake in astroglial primary cultures Newer anticonvulsants: comparative review of drug interactions and adverse effects. Lamotrigine plasma levels reduced by oral contraceptives Lack of an effect of valproate concentration on lamotrigine pharmacokinetics in developmentally disabled patients with epilepsy. Lamotrigine. A review of its use in childhood epilepsy Factors Influencing the Incidence of Lamotrigine-Related Skin Rash Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs Differential effects of valproic acid and enzyme-inducing anticonvulsants on nimodipine pharmacokinetics in epileptic patients The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability. New micromethod for the determination of lamotrigine in human plasma by high-performance liquid chromatography Validation of a population pharmacokinetic model for adjunctive lamotrigine therapy in children Newer antiepileptic drugs. Towards an improved risk-benefit ratio Lamotrigine pharmacokinetic evaluation in epileptic patients submitted to VEEG monitoring Population pharmacokinetics of lamotrigine adjunctive therapy in adults with epilepsy. Drug treatment of epilepsy in the 1990s. Achievements and new developments. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION. Antiepileptic medication interactions. Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients. Lamotrigine induced DRESS syndrome Impact of lamotrigine on patients with refractory epilepsy: the Leicester experience Factors that influence the pharmacokinetics of lamotrigine in Japanese patients with epilepsy Dosing recommendations based on population pharmacokinetics of lamotrigine in Mexican adult patients with epilepsy Misdiagnosis of lamotrigine toxicity as posterior circulation transient ischemic attack or stroke Lamotrigine pharmacokinetics in patients receiving felbamate Proof of principle trials: exploratory open studies
is cites work of	wds:Q33813315-EE2FB4A9-6982-441A-A418-6438F5AC6F57 wds:Q34306763-FD7F7ECD-1211-4478-AD61-8E803C5CB643 wds:Q33591073-7479465A-D138-4D08-95D3-A91F02120113 wds:Q80001318-0E35D2DB-97BF-454E-9290-40829036E4A3 wds:Q40720372-6200B4FE-64ED-4814-9D6E-CEF2BDCFD5A4 wds:Q35759136-B505D6F1-85C0-4A28-9A71-C152FDB1D8E4 wds:Q96353888-3A86F186-1473-415F-8843-3AE1297E7964 wds:Q97538359-DF9746B7-068C-4CAC-98F1-271201A05461 wds:Q41101288-E1705B85-45E9-4F00-8A9A-3753143EF55C wds:Q40932340-EBBB0467-F3F5-4C28-836A-1655DC4FFBB3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software